The European Medicines Agency has recommended that a licence should be granted for Siponimod for the treatment of active secondary progressive MS.
Siponimod recommended for secondary progressive MS by EMA
Posts with the Secondary Progressive tag
The European Medicines Agency has recommended that a licence should be granted for Siponimod for the treatment of active secondary progressive MS.